Status:
COMPLETED
Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section
Lead Sponsor:
Dow University of Health Sciences
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
the primary objective of the study is to compare the onset and recovery times of sensory and motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary objectives of t...
Detailed Description
The current study is undertaken to compare the effect of two drugs intrathecally.edexmedetomidine and fentanyl with a low dose of bupivacaine and assess the adequacy of the block, side effect profile ...
Eligibility Criteria
Inclusion
- Term pregnancy Singleton ASA I and II, BMI \<35, elective C/section
Exclusion
- patient refusal, contraindications to spinal anaesthesia. ASA III and IV, PIH Pre Eclampsia, allergic to Local Anesthetic, fetal anomalies.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04095013
Start Date
February 1 2019
End Date
July 15 2019
Last Update
September 19 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Civil Hospital Karachi
Karachi, Sindh, Pakistan, 75520
2
DUHS, Civil hospital Karachi (CHK)
Karachi, Sindh, Pakistan, 75520